HKEX(HK:00388) Sou Hu Cai Jing·2025-09-30 12:35Group 1: Hong Kong IPO Market - The Hong Kong IPO market has seen a significant increase in activity, with a total fundraising amount of approximately 1,823.97 billion HKD (234.37 billion USD) in the first nine months of 2025, representing a year-on-year increase of 227.15% [2] - In Q3 2025, the fundraising amount reached 735.17 billion HKD (94.47 billion USD), which, despite being lower than the previous quarter, was still 74.12% higher than the same period last year [2] - Major IPOs in Q3 included Zijin Gold International and Chery Automobile, raising 249.84 billion HKD (32.10 billion USD) and 91.45 billion HKD (11.75 billion USD) respectively [9][10] Group 2: Comparison with US IPO Market - The US IPO market has shown a different trend, with the Nasdaq and NYSE raising 15.075 billion USD and 15.204 billion USD respectively in the first three quarters of 2025, marking year-on-year increases of 7.73% and 29.78% [2] - Despite the overall lower fundraising in the US compared to Hong Kong, the US market has seen notable IPOs driven by AI and stablecoin concepts, with companies like Klarna and Circle raising significant amounts [5][15] - The Nasdaq China Golden Dragon Index has increased by 28.69% this year, outperforming the S&P 500 and Nasdaq indices, yet the number of Chinese concept stocks going public in the US has significantly decreased [4][16] Group 3: Future Outlook - The Hong Kong IPO market is expected to remain active, with 331 applications pending as of late August 2025, and a notable increase in applications in September [12] - The trend of A-share companies choosing to list in Hong Kong is evident, with major firms like CATL and Hengrui Medicine leading the charge [10][14] - The ongoing interest in biotech companies, particularly unprofitable ones, has resulted in substantial stock price increases, indicating strong market support for innovative sectors [13][14]